Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health
在确保相关卫生技术评估的前提下,快速获取创新药品。法国国家卫生管理局的立场
期刊:Bmj Evidence-Based Medicine
影响因子:7.6
doi:10.1136/bmjebm-2022-112091
Vanier, Antoine; Fernandez, Judith; Kelley, Sophie; Alter, Lise; Semenzato, Patrick; Alberti, Corinne; Chevret, Sylvie; Costagliola, Dominique; Cucherat, Michel; Falissard, Bruno; Gueyffier, François; Lambert, Jérôme; Lengliné, Etienne; Locher, Clara; Naudet, Florian; Porcher, Raphael; Thiébaut, Rodolphe; Vray, Muriel; Zohar, Sarah; Cochat, Pierre; Le Guludec, Dominique